EDP Sciences logo
Subscriber Authentication Point
Sciengine logo
Search
Menu
All issues Volume 21 (2026) Math. Model. Nat. Phenom., 21 (2026) 11 References
Open Access
Issue
Math. Model. Nat. Phenom.
Volume 21, 2026
Article Number 11
Number of page(s) 47
Section Mathematical physiology and medicine
DOI https://doi.org/10.1051/mmnp/2026002
Published online 06 April 2026
  1. J. Ferlay, M. Ervik, F. Lam, M. Laversanne, M. Colombet, L. Mery, M. Pineros, A. Znaor, I. Soerjomataram and F. Bray, Global cancer observatory: cancer today (version 1.1). International Agency for Research on Cancer, Lyon, France (2024). Available from: https://gco.iarc.who.int/today, accessed: 22/03/2024. [Google Scholar]
  2. T.K. Palaniappan, L. Slekiene, A.-K. Jonasson, J. Gilthorpe and L. Gunhaga, CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells. Sci. Rep. 10 (2020) 10472. [Google Scholar]
  3. M. Piipponen, P. Riihilä, L. Nissinen and V.-M. Kähäri, The role of p53 in progression of cutaneous squamous cell carcinoma. Cancers 13 (2021) 4507. [Google Scholar]
  4. M. Tauro and C. Lynch, Cutting to the chase: how matrix metalloproteinase-2 activity controls breast-cancer-to-bone metastasis. Cancers 10 (2018) 185. [Google Scholar]
  5. A. Watanabe, D. Hosino, N. Koshikawa, M. Seiki, T. Suzuki and K. Ichikawa, Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia. PLoS Comput. Biol. 9 (2013) e1003086. [Google Scholar]
  6. T.H. Vu and Z. Werb, Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14 (2000) 2123–2133. [Google Scholar]
  7. E.I. Deryugina and J.P. Quigley, Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25 (2006) 9–34. [Google Scholar]
  8. G.A. Cabral-Pacheco, I. Garza-Veloz, C. Castruita-De La Rosa, J.M Ramirez-Acuna, B.A Perez-Romero, J.F Guerrero-Rodriguez, N. Martinez-Avila and M.L. Martinez-Fierro, The roles of matrix metalloproteinases and their inhibitors in human diseases. Int. J. Mol. Sci. 21 (2020) 9739. [Google Scholar]
  9. D. Hanahan and R.A. Weinberg, The hallmarks of cancer. Cell 100 (2000) 57–70. [CrossRef] [PubMed] [Google Scholar]
  10. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj and O. Pereira-Smith, A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9363–9367. [Google Scholar]
  11. L. Berben, G. Floris, H. Wildiers and S. Hatse, Cancer and aging: two tightly interconnected biological processes. Cancers 13 (2021) 1400. [Google Scholar]
  12. D. Hanahan, Hallmarks of cancer: new dimensions, Cancer Discov. 12 (2022) 31–46. [CrossRef] [PubMed] [Google Scholar]
  13. M. Fane and A.T. Weeraratna, How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer 20 (2020) 89–106. [Google Scholar]
  14. E. Kim, V. Rebecca, I.V. Fedorenko, J.L. Messina, R. Mathew, S.S. Maria-Engler, D. Basanta, K.S.M. Smalley and A.R.A. Anderson, Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Res. 73 (2013) 6874–6885. [Google Scholar]
  15. N. Malaquin, C. Vercamer, F. Bouali, S. Martien, E. Deruy, N. Wernert, M. Chwastyniak, F. Pinet, C. Abbadie, and A. Pourtier, Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis. PLoS One 8 (2013) e63607. [Google Scholar]
  16. P.M. Altrock, L.L. Liu and F. Michor, The mathematics of cancer: integrating quantitative models. Nat. Rev. Cancer 15 (2015) 730–745. [Google Scholar]
  17. A.R.A. Anderson and V. Quaranta, Integrative mathematical oncology. Nat. Rev. Cancer 8 (2008) 227–234. [Google Scholar]
  18. A.P. Browning, P. Haridas and M.J. Simpson, A Bayesian sequential learning framework to parameterise continuum models of melanoma invasion into human skin. Bull. Math. Biol. 81 (2019) 676–698. [Google Scholar]
  19. M.J Simpson, R.J. Murphy and O.J Maclaren, Modelling count data with partial differential equation models in biology. J. Theoret. Biol. 580 (2024) 111732. [Google Scholar]
  20. H. Enderling and M. Chaplain, Mathematical modeling of tumor growth and treatment. Curr. Pharm. Des. 20 (2014) 4934–4940. [CrossRef] [Google Scholar]
  21. N. Sfakianakis and M.A.J. Chaplain, Mathematical Modelling of Cancer Invasion: A Review, Methods of Mathematical Oncology, vol. 370, edited by T. Suzuki, C. Poignard, M. Chaplain and V. Quaranta. Springer Singapore, Singapore (2021) 153–172. [Google Scholar]
  22. Y. Kim and A. Friedman, Interaction of tumor with its micro-environment: a mathematical model. Bull. Math. Biol. 72 (2010) 1029–1068. [Google Scholar]
  23. Y. Kim, J. Wallace, F. Li, M. Ostrowski and A. Friedman, Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments. J. Math. Biol. 61 (2010) 401–421. [Google Scholar]
  24. Z. Heidary, J. Ghaisari, S. Moein and S. Haghjooy Javanmard, The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach. PLoS One 15 (2020) e0232965. [Google Scholar]
  25. O. Gallinato, T. Colin, O. Saut and C. Poignard, Tumor growth model of ductal carcinoma: from in situ phase to stroma invasion. J. Theor. Biol. 429 (2017) 253–266. [Google Scholar]
  26. A. Donze, E. Fanchon, L.M. Gattepaille, O. Maler and P. Tracqui, Robustness analysis and behavior discrimination in enzymatic reaction networks. PLoS One 6 (2011) e24246. [Google Scholar]
  27. D. Hoshino, N. Koshikawa, T. Suzuki, V. Quaranta, A.M. Weaver, M. Seiki and K. Ichikawa, Establishment and validation of computational model for MT1-MMP dependent ECM degradation and intervention strategies. PLoS Comput. Biol. 8 (2012) e1002479. [Google Scholar]
  28. E.D. Karagiannis and A.S. Popel, A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. J. Biol. Chem. 279 (2004) 39105–39114. [Google Scholar]
  29. T. Saitou, K. Itano, D. Hoshino, N. Koshikawa, M. Seiki, K. Ichikawa and T. Suzuki, Control and inhibition analysis of complex formation processes. Theor. Biol. Med. Model. 9 (2012) 33. [Google Scholar]
  30. M.A.J. Chaplain and G. Lolas, Mathematical modelling of cancer invasion of tissue: dynamic heterogeneity. Netw. Heterog. Media 1 (2006) 399–439. [CrossRef] [MathSciNet] [Google Scholar]
  31. N.E. Deakin and M.A.J. Chaplain, Mathematical modeling of cancer invasion: the role of membrane-bound matrix metalloproteinases. Front. Oncol. 3 (2013) 70. [Google Scholar]
  32. J. Joshi, M.D. Abnavi and C.R. Kothapalli, Synthesis and secretome release by human bone marrow mesenchymal stem cell spheroids within three-dimensional collagen hydrogels: integrating experiments and modelling. J. Tissue Eng. Regen. Med. 13 (2019), 1923–1937. [Google Scholar]
  33. J. Panovska and G. Pettet, Mathematical model for glioma cell invasion, Unpublished (2007). [Google Scholar]
  34. K.M. Mak and R. Mei, Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease. Anat. Rec. 300 (2017) 1371–1390. [Google Scholar]
  35. B. Ribba, O. Saut, T. Colin, D. Bresch, E. Grenier and J.P. Boissel, A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J. Theor. Biol. 243 (2006) 532–541. [Google Scholar]
  36. M.A.J. Chaplain, C. Giverso, T. Lorenzi and L. Preziosi, Derivation and application of effective interface conditions for continuum mechanical models of cell invasion through thin membranes. SIAM J. Appl. Math. 79 (2019) 2011–2031. [Google Scholar]
  37. M.A. Cepeda, J.J.H. Pelling, C.L. Evered, K.C. Williams, Z. Freedman, I. Stan, J.A. Willson, H.S. Leong and S. Damjanovski, Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells. Mol. Cancer 15 (2016) 65. [Google Scholar]
  38. K.V Lu, K.A. Jong, A.K. Rajasekaran, T.F. Cloughesy and P.S. Mischel, Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab. Invest. 84 (2004) 8–20. [Google Scholar]
  39. E.I. Deryugina, M.A. Bourdon, K. Jungwirth, J.W. Smith and A.Y. Strongin, Functional activation of integrin αv/β3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int. J. Cancer 86 (2000) 15–23. [Google Scholar]
  40. P. Domschke, D. Trucu, A. Gerisch and M.A.J. Chaplain, Mathematical modelling of cancer invasion: implications of cell adhesion variability for tumour infiltrative growth patterns. J. Theor. Biol. 361 (2014) 41–60. [Google Scholar]
  41. F. Laurino and P. Zunino, Derivation and analysis of coupled PDEs on manifolds with high dimensionality gap arising from topological model reduction. ESAIM. Math. Model. Numer. Anal. 53 (2019) 2047–2080. [Google Scholar]
  42. A. Albini, Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. Kozlowski and R.N. McEwan, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47 (1987) 3239–3245. [Google Scholar]
  43. M. Toth, M. Margarida Bernardo, D.C. Gervasi, P.D. Soloway, Z. Wang, H.F. Bigg, C.M. Overall, Y.A. DeClerck, H. Tschesche, M.L. Cher, S. Brown, S. Mobashery and R. Fridman, Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of Pro-MMP-2. J. Biol. Chem. 275 (2000) 41415–41423. [Google Scholar]
  44. M.W. Olson, D.C. Gervasi, S. Mobashery and R. Fridman, Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272 (1997) 29975–29983. [Google Scholar]
  45. S. Momi, E. Falcinelli, S. Giannini, L. Ruggeri, L. Cecchetti, T. Corazzi, C. Libert and P. Gresele, Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J. Exp. Med. 206 (2009) 2365–2379. [Google Scholar]
  46. J.M. Castellano, K.I. Mosher, R.J. Abbey, A.A. McBride, M.L. James, D. Berdnik, J.C.. Shen, B. Zou, X.S. Xie, M. Tingle, I.V. Hinkson, M.S. Angst and T. Wyss-Coray, Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 544 (2017) 488–492. [Google Scholar]
  47. I.E. Collier, W. Legant, B. Marmer, O. Lubman, S. Saffarian, T. Wakatsuki, E. Elson and G.I. Goldberg, Diffusion of MMPs on the surface of collagen fibrils: the mobile cell surface - collagen substratum interface. PLoS One 6 (2011) e24029. [Google Scholar]
  48. K. Paula, T.-M. Anne and T.-H. Taina, The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in circulating blood of healthy controls and breast cancer patients. Biomark. Insights 2 (2007) 117–127. [Google Scholar]
  49. E. Roig-Rosello and P. Rousselle, The human epidermal basement membrane: a shaped and cell instructive platform that aging slowly alters. Biomolecules 10 (2020) 1607. [Google Scholar]
  50. P. Laudanski, J. Swiatecka, L. Kozlowski, M. Lesniewska, M. Wojtukiewicz and S. Wolczynski, Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer. Folia Histochem. Cytobiol. 48 (2010) 101–103. [Google Scholar]
  51. M.A. Chellaiah and T. Ma, Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts. Biomed. Res. Int. 2013 (2013) 1–13. [Google Scholar]
  52. K.-i. Shimokawa, Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma. Mol. Hum. Reprod. 8 (2002) 32–36. [Google Scholar]
  53. W.G. Stetler-Stevenson, The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev. 27 (2008) 57–66. [Google Scholar]
  54. T.-M. Anne and T.-H. Taina, Levels of circulating TIMP-2 and MMP2-TIMP2 complex are decreased in squamous cervical carcinoma. Obstet. Gynecol. Int. 2010 (2010) 179351. [Google Scholar]
  55. F. Pianosi, F. Sarrazin and T. Wagener, A Matlab toolbox for global sensitivity analysis. Environ. Model. Softw. 70 (2015) 80–85. [Google Scholar]
  56. L. Almeida, A. Poulain, A. Pourtier and C. Villa, alexandrepoulain/tuminvasion-bm: Bm rupture code (2024). [Google Scholar]
  57. F. Pianosi, K. Beven, J. Freer, J.W. Hall, J. Rougier, D.B. Stephenson and T. Wagener, Sensitivity analysis of environmental models: a systematic review with practical workflow. Environ. Model Softw. 79 (2016) 214–232. [Google Scholar]
  58. M.D. Morris, Factorial sampling plans for preliminary computational experiments. Technometrics 33 (1991) 161–174. [CrossRef] [Google Scholar]
  59. B. Iooss and P. Lemaître, A Review on Global Sensitivity Analysis Methods, Uncertainty Management in Simulation-Optimization of Complex Systems, vol. 59, edited by G. Dellino and C. Meloni. Springer US, Boston, MA (2015) 101–122. [Google Scholar]
  60. R. Jayadev and D.R. Sherwood, Basement membranes. Curr. Biol. 27 (2017) R207-R211. [Google Scholar]
  61. W.H. Fissell, C.L. Hofmann, N. Ferrell, L. Schnell, A. Dubnisheva, A.L. Zydney, P.D. Yurchenco and S. Roy, Solute partitioning and filtration by extracellular matrices. Am. J. Physiol. Renal Physiol. 297 (2009) F1092-F1100. [Google Scholar]
  62. H. Huang, Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and mmp-9 biosensors: recent advances. Sensors 18 (2018) 3249. [Google Scholar]
  63. P. Baluk, S. Morikawa, A. Haskell, M. Mancuso and D.M. McDonald, Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163 (2003) 1801–1815. [Google Scholar]
  64. S. Marusic and E. Marusic-Paloka, Two-scale convergence for thin domains and its applications to some lower-dimensional models in fluid mechanics. Asymptot. Anal. 23 (2000) 23–57. [Google Scholar]
  65. A. Leinonen, M. Mariyama, T. Mochizuki, K. Tryggvason and S.T. Reeders, Complete primary structure of the human type iv collagen alpha 4(iv) chain. Comparison with structure and expression of the other alpha (iv) chains. J. Biol. Chem. 269 (1994) 26172–26177. [Google Scholar]
  66. P. Henriet and H. Emonard, Matrix metalloproteinase-2: not (just) a "hero" of the past. Biochimie 166 (2019) 223–232. [Google Scholar]
  67. A. Jiang, K. Lehti, X. Wang, S.J. Weiss, J. Keski-Oja and D. Pei, Regulation of membrane-type matrix metallo-proteinase 1 activity by dynamin-mediated endocytosis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13693–13698. [Google Scholar]
  68. H. Emonard, G. Bellon, L. Troeberg, A. Berton, A. Robinet, P. Henriet, E. Marbaix, K. Kirkegaard, L. Patthy, Y. Eeckhout, H. Nagase, W. Hornebeck and P.J. Courtoy, Low density lipoprotein receptor-related protein mediates endocytic clearance of Pro-MMP-2-TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279 (2004) 54944–54951. [Google Scholar]
  69. M. Demestre, G. Parkin-Smith, A. Petzold and A.H. Pullen, The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J. Neuroimmunol. 159 (2005) 146–154. [Google Scholar]
  70. R.J. LeVeque, Finite difference methods for ordinary and partial differential equations: steady-state and time-dependent problems. SIAM (2007) 1–341. [Google Scholar]
  71. R. Eymard, T. Gallouet and R. Herbin, Finite volume methods. Handbook of Numerical Analysis, Vol. VII. North-Holland, Amsterdam (2000), pp. 713–1020. [Google Scholar]
  72. L.F. Shampine and M.W. Reichelt, The MATLAB ODE suite. SIAM J. Sci. Comput. 18 (1997) 1–22. [NASA ADS] [CrossRef] [Google Scholar]
  73. D. Hanahan and R.A. Weinberg, Hallmarks of cancer: the next generation. Cell 144 (2011) 646–674. [CrossRef] [PubMed] [Google Scholar]
  74. M.C. White, D.M. Holman, J.E. Boehm, L.A. Peipins, M. Grossman and S. Jane Henley, Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46 (2014) S7-S15. [Google Scholar]
  75. W. Hu, L. Fang, R. Ni, H. Zhang and G. Pan, Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 22 (2022) 836. [Google Scholar]
  76. F. Hillen and A.W. Griffioen, Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 26 (2007) 489–502. [Google Scholar]
  77. E. Laconi, F. Marongiu and J. DeGregori, Cancer as a disease of old age: changing mutational and microenviron-mental landscapes. Br. J. Cancer 122 (2020) 943–952. [Google Scholar]
  78. C. Frantz, K.M. Stewart and V.M. Weaver, The extracellular matrix at a glance. J. Cell Sci. 123 (2010) 4195–4200. [Google Scholar]
  79. J.K. Kular, S. Basu and R.I. Sharma, The extracellular matrix: Structure, composition, age-related differences, tools for analysis and applications for tissue engineering. J. Tissue Eng. 5 (2014) 204173141455711. [Google Scholar]
  80. H. Laronha and J. Caldeira, Structure and function of human matrix metalloproteinases. Cells 9 (2020) 1076. [Google Scholar]
  81. H.E. Van Wart and H. Birkedal-Hansen, The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 5578–5582. [Google Scholar]
  82. U.B. Hofmann, J.R. Westphal, G.N.P. van Muijen and D.J. Ruiter, Matrix metalloproteinases in human melanoma. J. Invest. Dermatol. 115 (2000) 337–344. [Google Scholar]
  83. G. Murphy, Tissue inhibitors of metalloproteinases. Genome Biol. 12 (2011) 1–7. [Google Scholar]
  84. I. Ben-Porath and R.A. Weinberg, When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113 (2004) 8–13. [Google Scholar]
  85. Z. Liao, H.L. Yeo, S.W. Wong and Y. Zhao, Cellular senescence: Mechanisms and therapeutic potential. Biomedicines 9 (2021) 1769. [Google Scholar]
  86. I. Luähr, A. Friedl, T. Overath, A. Tholey, T. Kunze, F. Hilpert, S. Sebens, N. Arnold, F. Räosel, H.-H. Oberg, N. Maass, C. Mundhenke, W. Jonat and M. Bauer, Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals. Cancer Lett. 325 (2012) 175–188. [Google Scholar]
  87. J.-P. Coppe, M. Boysen, C.H. Sun, B.J.F. Wong, M.K. Kang, N.-H. Park, P.-Y. Desprez, J. Campisi and A. Krtolica, A role for fibroblasts in mediating the effects of tobacco-induced epithelial cell growth and invasion. Mol. Cancer Res. 6 (2008) 1085–1098. [Google Scholar]
  88. J.-P. Coppe, P.-Y. Desprez, A. Krtolica and J. Campisi, The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. Mech. Dis. 5 (2010) 99–118. [Google Scholar]
  89. Y. Hassona, N. Cirillo, K. Heesom, E.K. Parkinson and S.S. Prime, Senescent cancer-associated fibroblasts secrete active mmp-2 that promotes keratinocyte dis-cohesion and invasion. Br. J. Cancer 111 (2014) 1230–1237. [Google Scholar]
  90. A. Krtolica, S. Parrinello, S. Lockett, P.-Y. Desprez and J. Campisi, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12072–12077. [Google Scholar]
  91. P.J. Asif, C. Longobardi, M. Hahne and J.P. Medema, The role of cancer-associated fibroblasts in cancer invasion and metastasis. Cancers 13 (2021) 4720. [Google Scholar]
  92. T. Wang, F. Notta, R. Navab, J. Joseph, E. Ibrahimov, J. Xu, C.-Q. Zhu, A. Borgida, S. Gallinger and M.-S. Tsao, Senescent carcinoma-associated fibroblasts upregulate IL8 to enhance prometastatic phenotypes. Mol. Cancer Res. 15 (2017) 3–14. [Google Scholar]
  93. D. Fabian and T. Flatt, The evolution of aging. Nat. Educ. Knowl. 3 (2011) 1–10. [Google Scholar]
  94. M.R. Rose, Evolutionary Biology of Aging. Oxford University Press (1994). [Google Scholar]
  95. D.J. Baker, T. Wijshake, T. Tchkonia, N.K. LeBrasseur, B.G. Childs, B. Van De Sluis, J.L. Kirkland and J.M. Van Deursen, Clearance of p16ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011) 232–236. [Google Scholar]
  96. L. Grosse, N. Wagner, A. Emelyanov, C. Molina, S. Lacas-Gervais, K.-D. Wagner and D.V. Bulavin, Defined p16high senescent cell types are indispensable for mouse healthspan. Cell Metab. 32 (2020) 87-99.e6. [Google Scholar]
  97. J. Giroud, I. Bouriez, H. Paulus, A. Pourtier, F. Debacq-Chainiaux and O. Pluquet, Exploring the communication of the SASP: dynamic, interactive, and adaptive effects on the microenvironment. Int. J. Mol. Sci. 24 (2023) 10788. [Google Scholar]
  98. E.C. Woenne, W. Lederle, S. Zwick, M. Palmowski, H. Krell, W. Semmler, M.M. Mueller and F. Kiessling, MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters vegf-a and pdgf-bb expression. Anticancer Res. 30 (2010) 703–711. [Google Scholar]
  99. N.J. Aherne, A. Dhawan, J.G. Scott and H. Enderling, Mathematical oncology and it's application in non melanoma skin cancer. Oral Oncol. 103 (2020) 104473. [Google Scholar]
  100. D. Barbolosi, J. Ciccolini, B. Lacarelle, F. Barlesi and N. Andre, Computational oncology—mathematical modelling of drug regimens for precision medicine. Nat. Rev. Clin. Oncol. 13 (2016) 242–254. [Google Scholar]
  101. S. Bekisz and L. Geris, Cancer modeling: from mechanistic to data-driven approaches, and from fundamental insights to clinical applications. J. Computat. Sci. 46 (2020) 101198. [Google Scholar]
  102. J.A. Bull and H.M. Byrne, The hallmarks of mathematical oncology. Proc. IEEE 110 (2022) 523–540. [Google Scholar]
  103. R.C Rockne, A. Hawkins-Daarud, K.R. Swanson, J.P. Sluka, J.A. Glazier, P. Macklin, D.A. Hormuth, A.M. Jarrett, E.A.B.F. Lima, J. Tinsley Oden, et al., The 2019 mathematical oncology roadmap. Phys. Biol. 16 (2019) 041005. [Google Scholar]
  104. T. Hernandez-Boussard, P. Macklin, E.J. Greenspan, A.L. Gryshuk, E. Stahlberg, T. Syeda-Mahmood and I. Shmulevich, Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat. Med. 27 (2021) 2065–2066. [Google Scholar]
  105. C. Wu, G. Lorenzo, D.A. Hormuth, E.A.B.F. Lima, K.P. Slavkova, J.C. DiCarlo, J. Virostko, C.M. Phillips, D. Patt, C. Chung and T.E. Yankeelov, Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. Biophys. Rev. 3 (2022) 021304. [Google Scholar]
  106. R.A Gatenby and E.T. Gawlinski, A reaction-diffusion model of cancer invasion. Cancer Res. 56 (1996) 5745–5753. [Google Scholar]
  107. L. Bartha and R. Eftimie, Mathematical investigation into the role of macrophage heterogeneity on the temporal and spatio-temporal dynamics of non-small cell lung cancers. J. Theor. Biol. 549 (2022) 111207. [Google Scholar]
  108. R. Eftimie and L. Gibelli, A kinetic theory approach for modelling tumour and macrophages heterogeneity and plasticity during cancer progression. Math. Models Methods Appl. Sci. 30 (2020) 659–683. [Google Scholar]
  109. H. Knútsdóttir, E. Pálsson and L. Edelstein-Keshet, Mathematical model of macrophage-facilitated breast cancer cells invasion. J. Theor. Biol. 357 (2014) 184–199. [Google Scholar]
  110. G. Mahlbacher, L.T. Curtis, J. Lowengrub and H.B. Frieboes, Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment. J. Immunother. Cancer 6 (2018) 1–17. [Google Scholar]
  111. M.R Owen and J.A. Sherratt, Mathematical modelling of macrophage dynamics in tumours. Math. Models Methods Appl. Sci. 9 (1999) 513–539. [Google Scholar]
  112. S. Suveges, R. Eftimie and D. Trucu, Directionality of macrophages movement in tumour invasion: a multiscale moving-boundary approach. Bull. Math. Biol. 82 (2020) 1–50. [Google Scholar]
  113. A. Friedman, C. Huang and J. Yong, Effective permeability of the boundary of a domain. Commun. Part. Differ. Equ. 20 (1995) 59–102. [Google Scholar]
  114. O. Kedem and A. Katchalsky, Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. Biochim. Biophys. Acta 27 (1958) 229–246. [Google Scholar]
  115. F.W. Kleinhans, Membrane permeability modeling: Kedem-katchalsky vs a two-parameter formalism. Cryobiology 37 (1998) 271–289. [Google Scholar]
  116. C. Giverso, T. Lorenzi and L. Preziosi, Effective interface conditions for continuum mechanical models describing the invasion of multiple cell populations through thin membranes. Appl. Math. Lett. 125 (2022) 107708. [Google Scholar]
  117. G. Ciavolella, N. David and A. Poulain, Effective interface conditions for a porous medium type problem. Interfaces Free Bound. (2024). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.